Cargando…
Who or What is SHERLOCK?
BACKGROUND: Polymerase chain reaction (PCR) is the most commonly used method for detecting nucleic acids. However, PCR requires specialized and expensive equipment, as well as specially trained personnel. Recently, new innovative diagnostic methods have been developed to detect nucleic acids using t...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247122/ https://www.ncbi.nlm.nih.gov/pubmed/30479604 |
_version_ | 1783372450975711232 |
---|---|
author | Gronowski, Ann M. |
author_facet | Gronowski, Ann M. |
author_sort | Gronowski, Ann M. |
collection | PubMed |
description | BACKGROUND: Polymerase chain reaction (PCR) is the most commonly used method for detecting nucleic acids. However, PCR requires specialized and expensive equipment, as well as specially trained personnel. Recently, new innovative diagnostic methods have been developed to detect nucleic acids using the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) gene editing technology. OBJECTIVE: This manuscript reviews the newly emerging diagnostic methods that exploit the CRISPR technology. RESULTS: The programmable endonuclease properties of CRISPR have been harnessed for use in diagnostic testing. Specific High-sensitivity Enzymatic Reporter un-LOCKing (SHERLOCK) and DNA Endonuclease Targeted CRISPR Trans Reporter (DETECTR) are diagnostic tools that can be used to detect specific RNA/DNA at low attomolar concentrations. Heating Unextracted Diagnostic Samples to Obliterate Nuclease (HUDSON), is a process of heat and chemical reduction that allows for direct detection of nucleotides in body fluids. HUDSON and SHERLOCK can be combined to detect RNA/DNA directly from urine, saliva, serum, plasma, and whole blood with limited sample preparation or equipment with results in 1 to 2 hours. In addition, a lateral flow readout has been developed to facilitate assay detection. CONCLUSIONS: Potential uses of this emerging technology are numerous due to the analytical sensitivity and specificity, simplicity, speed, and flexibility. |
format | Online Article Text |
id | pubmed-6247122 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The Communications and Publications Division (CPD) of the IFCC |
record_format | MEDLINE/PubMed |
spelling | pubmed-62471222018-11-26 Who or What is SHERLOCK? Gronowski, Ann M. EJIFCC Discussion BACKGROUND: Polymerase chain reaction (PCR) is the most commonly used method for detecting nucleic acids. However, PCR requires specialized and expensive equipment, as well as specially trained personnel. Recently, new innovative diagnostic methods have been developed to detect nucleic acids using the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) gene editing technology. OBJECTIVE: This manuscript reviews the newly emerging diagnostic methods that exploit the CRISPR technology. RESULTS: The programmable endonuclease properties of CRISPR have been harnessed for use in diagnostic testing. Specific High-sensitivity Enzymatic Reporter un-LOCKing (SHERLOCK) and DNA Endonuclease Targeted CRISPR Trans Reporter (DETECTR) are diagnostic tools that can be used to detect specific RNA/DNA at low attomolar concentrations. Heating Unextracted Diagnostic Samples to Obliterate Nuclease (HUDSON), is a process of heat and chemical reduction that allows for direct detection of nucleotides in body fluids. HUDSON and SHERLOCK can be combined to detect RNA/DNA directly from urine, saliva, serum, plasma, and whole blood with limited sample preparation or equipment with results in 1 to 2 hours. In addition, a lateral flow readout has been developed to facilitate assay detection. CONCLUSIONS: Potential uses of this emerging technology are numerous due to the analytical sensitivity and specificity, simplicity, speed, and flexibility. The Communications and Publications Division (CPD) of the IFCC 2018-11-07 /pmc/articles/PMC6247122/ /pubmed/30479604 Text en Copyright © 2018 International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This is a Platinum Open Access Journal distributed under the terms of the Creative Commons Attribution Non-Commercial License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Discussion Gronowski, Ann M. Who or What is SHERLOCK? |
title | Who or What is SHERLOCK? |
title_full | Who or What is SHERLOCK? |
title_fullStr | Who or What is SHERLOCK? |
title_full_unstemmed | Who or What is SHERLOCK? |
title_short | Who or What is SHERLOCK? |
title_sort | who or what is sherlock? |
topic | Discussion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247122/ https://www.ncbi.nlm.nih.gov/pubmed/30479604 |
work_keys_str_mv | AT gronowskiannm whoorwhatissherlock |